This study describes a modified technique to fill the renal vasculature with a silicon rubber (Microfil) compound and obtain morphologic information about the intrarenal distribution of capillary blood flow under a variety of conditions. Kidneys and cremaster muscles of rats were perfused in vivo with Microfil using a perfusion pressure equal to the animal's mean arterial pressure at body temperature. Microfil did not alter arteriolar diameter or the pattern of flow in the microcirculation of the cremaster muscle. The modified protocol reproducibly filled the renal vasculature, including; glomerular, peritubular, and vasa recta capillaries. We compared the filling of the renal circulation in control rats with that seen in animals subjected to maneuvers reported to alter the intrarenal distribution of blood flow. Infusion of angiotensin II, hypotension, volume expansion, and mannitol- or furosemide-induced diuresis redistributed flow between renal cortical and medullary capillaries. The advantage of the current technique is that it provides anatomical information regarding the number, diameter, and branching patterns of capillaries in the postglomerular circulation critical in determining the intrarenal distribution of cortical and medullary blood flow.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475880 | PMC |
| http://dx.doi.org/10.14814/phy2.14065 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Chronic Nuclear Factor-Kappa B Inhibition Prevents Experimental Aging Nephropathy.
Gerontology
November 2024
Renal Division, Department of Clinical Medicine, Faculty of Medicine, University of São Paulo São Paulo, São Paulo, Brazil.
Article Synopsis
- The study explores the effects of Angiotensin-II and inflammation pathways on aging nephropathy, particularly their role in chronic kidney disease progression.
- Researchers tested Losartan alone and in combination with the NF-κB inhibitor PDTC on aging rats to see if these treatments could alleviate kidney damage.
- Results indicated that while Losartan showed some benefits, the combination of Losartan and PDTC effectively prevented kidney abnormalities, suggesting a potential new treatment strategy for age-related kidney decline.
Flexible Ureteroscopy with a Tip-bendable Suction Ureteral Access Sheath Versus Mini-Percutaneous Nephrolithotomy for Treatment of 2-3-cm Renal Stones: Study Protocol for an International, Multicenter, Randomized, Parallel-group, Noninferiority Trial.
Eur Urol Open Sci
December 2024
Department of Urology and Guangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Guidelines recommend percutaneous nephrolithotomy (PCNL) for larger renal stones, but advances in flexible ureteroscopy (f-URS) with a tip-bendable suction ureteral access sheath (S-UAS) have prompted further investigation. Our multicenter, international, randomized controlled trial is investigating whether f-URS with S-UAS is noninferior to mini-PCNL (mPCNL) for renal stones of 2-3 cm. The primary objective is the immediate stone-free rate (SFR).
View Article and Find Full Text PDFPeripheral dopamine suppression and elevated cystatin C in early diabetic nephropathy in spontaneously diabetic rats.
Am J Physiol Renal Physiol
October 2024
Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.
Article Synopsis
- Intrarenal dopamine helps protect against diabetic nephropathy in early-stage diabetes by reducing glomerular hyperfiltration, oxidative stress, inflammation, and fibrosis in mice models.
- The study used benserazide to investigate the effects of peripheral dopamine on kidney function in spontaneously diabetic Torii rats, showing that lower peripheral dopamine levels worsen renal dysfunction.
- Findings reveal that peripheral dopamine plays a crucial role in controlling oxidative stress and kidney performance during the early stages of diabetic nephropathy, evidenced by its effect on markers of renal dysfunction.
Metabolic Analysis and Renal Protective Effects of Linagliptin and Empagliflozin in Alport Syndrome.
Kidney360
July 2024
Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.
Key Points: Linagliptin reduces kidney function decline and extends lifespan in Alport syndrome mice. Inhibiting the generation of glucose metabolites could serve as a potential therapeutic strategy for the treatment of Alport syndrome.
Background: We previously demonstrated that empagliflozin (Empa), a sodium-glucose cotransporter-2 inhibitor, reduces intrarenal lipid accumulation and slows kidney function decline in experimental Alport syndrome (AS).
Amelioration of diabetic nephropathy in mice by a single intravenous injection of human mesenchymal stromal cells at early and later disease stages is associated with restoration of autophagy.
Stem Cell Res Ther
March 2024
Hebei Medical University-University of Galway Stem Cell Research Center, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China.
Background And Aims: Mesenchymal stromal cells (MSCs) a potentially effective disease-modulating therapy for diabetic nephropathy (DN) but their clinical translation has been hampered by incomplete understanding of the optimal timing of administration and in vivo mechanisms of action. This study aimed to elucidate the reno-protective potency and associated mechanisms of single intravenous injections of human umbilical cord-derived MSCs (hUC-MSCs) following shorter and longer durations of diabetes.
Methods: A streptozotocin (STZ)-induced model of diabetes and DN was established in C57BL/6 mice.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!